Are you considering enrolling in pharmaceutical courses? If so, the future looks promising. The pharmaceutical industry in Canada and around the world is growing, opening up many opportunities for new graduates to start their careers. Taking courses at a top pharmaceutical school makes all the difference. AAPS is known for producing well-rounded, qualified, and capable students. As a result, our graduates, whether they study online or onsite, have the highest employment rate in the entire industry. If you’re trying to decide whether to enroll in online or onsite classes, read on to learn more about how to choose the best.. READ MORE »
Pharmaceuticals on the market have the ability to improve the lives of many Canadians. They are used to treat illness, pain, and disorders, and they help people live normal and healthier lives. But if individuals taking pharmaceuticals and the doctors who are prescribing them don’t have the proper information, issues may arise. This is why Health Canada ensures most approved drugs have a product monograph. A product monograph is a government-regulated scientific document that lists the drug, its properties, and any health claims the product makes. It includes essential information for doctors and healthcare professionals which allows them to make.. READ MORE »
Vaccines are one of the most useful medical creations of all time. They involve introducing antigens—a substance that the immune system will attack, like dead or weakened viruses—into the body, typically via injection. This can allow people to develop immunities to a range of illnesses, and also to do a better job of fighting against illnesses they have. Many illnesses—like measles, mumps, polio, and more—were once incredibly deadly and affected many people. By preventing the spread of deadly diseases and helping people manage illnesses they already have, vaccines have saved millions of lives over the past centuries. Today, there are.. READ MORE »
It is estimated by the Alzheimer Society of Canada that about 564,000 Canadians will suffer from dementia in 2016. Medical professionals will diagnose an additional 25,000 cases every single year, and by 2031 it is believed the number of patients suffering from dementia will rise to 937,000. Dementia is a huge problem not only in Canada, but across the globe. Unfortunately, there haven’t been any significant scientific breakthroughs that could slow the progress of the disease—until now. If you’re a student enrolled in a pharmaceutical program, you may understand the groundbreaking impact this scientific breakthrough could bring to dementia patients… READ MORE »
New drugs are developed, tested, processed, marketed, and then eventually released to the public every year. During their rigorous testing process, side effects arise in clinical trial patients and are noted by doctors. It is common for drugs to enter the market with a list of side effects, some being beneficial, but most being negative. These negative side effects are known as adverse effects. After a drug has been released to the market, there are systems in place so that healthcare professionals can report any new issues or serious reactions to drug. These are known as adverse drug reactions (ADRs)… READ MORE »
Researchers have developed a prototype that manufactures pharmaceuticals in a new way, potentially changing the pharmaceutical production industry forever.
The pan-Canadian Pharmaceutical Alliance (pCPA) includes all 13 provinces and territories, as well as the Federal Government, and negotiates to decrease the price of both generic and brand name drugs for Canadians. According to the Canadian Institute for Health Information, Canadians spent $28.8 billion on prescription drugs in 2014, and this spending is actually down from the $33 billion Canadians spent in 2012. The CIHI also notes that the growth rate of Canadian pharmaceutical spending is quite low. This may all be due to effective negotiation measures taken by the pCPA. Read on to discover how the pCPA makes sure.. READ MORE »
The pharmaceutical industry is one of the most regulated industries on the planet—and with good reason. Whether a pharmaceutical product is providing much-needed pain-relief to a patient or helping to rid them of a tough bacterial infection, pharmaceutical products need to work properly and predictably each time they are taken. That’s why drug manufacturers need to employ dedicated professionals with a top education in order to ensure that pharmaceutical products are always of the highest quality. If you’re interested in this in-demand career path, then completing your diploma in quality assurance and quality control is crucial. Throughout your training, you’ll.. READ MORE »
Many pharmaceutical products developed and manufactured in Canada are exported to the United States. As a result, while Canadian regulatory affairs professionals answer primarily to Health Canada, they must also pay special attention to the department’s U.S. equivalent, the Food and Drug Administration (FDA). The FDA officially came into being in 1906, after the Food and Drug Act was signed into law, with the aim of overseeing products and ensuring a high standard of “strength, quality and purity.” Over the years, the department’s powers have expanded significantly, and today the FDA regulates everything from food and drug products to potentially.. READ MORE »
Today, many of us take for granted that when we use a medication, we are certain that all of the contents inside the package are written out on its label. We know that our pharmaceuticals are safe and that they have been properly manufactured, tested, and labelled by dedicated professionals with GMP training. But what was life like before there were good manufacturing practises? Before strict regulations were in place and trained professionals knew how to properly test products for consistency and safety? Read on to learn what Canada’s pharmaceutical industry was like before regulation, and find out how important.. READ MORE »
